300404SZSE
🚨 Material Event

Announcement on Abnormal Stock Trading Fluctuations

Boji Pharmaceutical Co., Ltd.··2 pages

✨ AI Summary

Boji Medicine Technology Co., Ltd. announces abnormal stock trading fluctuations, with cumulative price deviation exceeding 30% over three consecutive trading days. The company has verified that there is no undisclosed material information, and its operations are normal. The announcement also details a proposed private placement of shares to raise up to RMB 446.64 million.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

BOJIMED

博济医药

Securities Code: 300404

Securities Abbreviation: Boji Medicine

Boji Medicine Technology Co., Ltd.

Announcement on Abnormal Stock Trading Fluctuations

Announcement No.: 2026-049

The Company and the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.

I. Description of Abnormal Stock Trading Fluctuations

The stock of Boji Medicine Technology Co., Ltd. (hereinafter referred to as the "Company") (Securities Abbreviation: Boji Medicine, Securities Code: 300404) experienced cumulative price deviation exceeding 30% over three consecutive trading days: August 12, 2026, August 13, 2026, and August 14, 2026. In accordance with the relevant regulations of the Shenzhen Stock Exchange, this constitutes an abnormal stock trading fluctuation.

II. Company's Verification and Explanation

The Company's Board of Directors has verified the abnormal stock trading fluctuations with the Company, its controlling shareholder, and its actual controller. The relevant situation is hereby announced as follows:

  1. The information previously disclosed by the Company requires no correction or supplement.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.